Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Hall

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
JMIR Research Protocols|September 20, 2021
The Finding My Way UK Clinical Trial: Adaptation Report and Protocol for a Replication Randomized Controlled Efficacy Trial of a Web-Based Psychological Program to Support Cancer SurvivorsNicholas J Hulbert-Williams, Monica Leslie, Lee Hulbert-Williams, et al.
Cancers|May 13, 2023
Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma-A Post-hoc Analysis of the GO2 TrialMark A Baxter, Lindsay C Spender, Shaun Walsh, et al.
Health Technology Assessment (Winchester, England)|June 5, 2018
The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisationPeter S Hall, Elizabeth D Mitchell, Alison F Smith, et al.
Health Technology Assessment (Winchester, England)|August 18, 2025
Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCTRustam Al-Shahi Salman, Neil Kitchen, Laura Forsyth, et al.
JAMA Network Open|February 23, 2023
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint InhibitorsDaniel A Goldstein, Gary M Ginsberg, Dorit Hofnung-Gabbay, et al.
BMJ (Clinical Research Ed.)|June 17, 2020
Distinguishing between direct and indirect consequences of covid-19Jonine D Figueroa, Paul M Brennan, Evropi Theodoratou, et al.
The Oncologist|January 31, 2023
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer TreatmentKarin Purshouse, John P Thomson, Mahéva Vallet, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim TrialPeter S Hall, Alison Smith, Claire Hulme, et al.
BMJ Open|November 29, 2023
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocolMark A Hull, Pei Loo Ow, Sharon Ruddock, et al.
Lancet (London, England)|February 1, 2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trialJanet A Dunn, Peter Donnelly, Nada Elbeltagi, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
JMIR Research Protocols|September 20, 2021
The Finding My Way UK Clinical Trial: Adaptation Report and Protocol for a Replication Randomized Controlled Efficacy Trial of a Web-Based Psychological Program to Support Cancer SurvivorsNicholas J Hulbert-Williams, Monica Leslie, Lee Hulbert-Williams, et al.
Cancers|May 13, 2023
Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma-A Post-hoc Analysis of the GO2 TrialMark A Baxter, Lindsay C Spender, Shaun Walsh, et al.
Health Technology Assessment (Winchester, England)|June 5, 2018
The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisationPeter S Hall, Elizabeth D Mitchell, Alison F Smith, et al.
Health Technology Assessment (Winchester, England)|August 18, 2025
Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCTRustam Al-Shahi Salman, Neil Kitchen, Laura Forsyth, et al.
JAMA Network Open|February 23, 2023
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint InhibitorsDaniel A Goldstein, Gary M Ginsberg, Dorit Hofnung-Gabbay, et al.
BMJ (Clinical Research Ed.)|June 17, 2020
Distinguishing between direct and indirect consequences of covid-19Jonine D Figueroa, Paul M Brennan, Evropi Theodoratou, et al.
The Oncologist|January 31, 2023
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer TreatmentKarin Purshouse, John P Thomson, Mahéva Vallet, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim TrialPeter S Hall, Alison Smith, Claire Hulme, et al.
BMJ Open|November 29, 2023
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocolMark A Hull, Pei Loo Ow, Sharon Ruddock, et al.
Lancet (London, England)|February 1, 2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trialJanet A Dunn, Peter Donnelly, Nada Elbeltagi, et al.
Pageof 6